Clovis Oncology Denmark ApS: Financial statements 2019
CVR: 38721682
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
Clovis Oncology Denmark ApS (CVR 38721682) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,924,969 and a net result of DKK 65,187 compared with DKK 21,308 the year before. That is a decrease of 56.8% compared with the year before. Equity in the 2019 report amounted to DKK 208,830. The solvency ratio was 25.3%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,924,969
- Profit/Loss
- DKK 65,187
- Equity
- DKK 208,830
- Total Assets
- DKK 826,862
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
Clovis Oncology Denmark ApS has published its annual report for 2018. Gross profit came to DKK 4,455,865, and the net result was DKK 21,308.
About Clovis Oncology Denmark ApS
Clovis Oncology Denmark ApS was a Danish company of the type Anpartsselskab based in Allerød, founded in 2017. The company has been dissolved on 5 June 2025. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -1,276,497 and a net result of DKK -1,290,249 compared with DKK -683,391 the year before. Equity in the 2023 report amounted to DKK -356,205.